Listen to audio brief:

On May 5, 2025, President Trump announced new measures to enhance domestic pharmaceutical manufacturing. He signed an Executive Order directing the FDA to simplify the approval process for manufacturing plants and increase inspections of foreign facilities. This initiative aims to secure the supply chain for medicines in the United States, promote investment in local production, and reduce reliance on international sources.

Original: article